Dan Nathan and Deirdre Bosa of CNBC discuss the AI fever breaking (2:00), Amazon (8:00), high valuation stocks deflating (12:30), the magnificent seven (or hateful eight) (15:30), and Zoom getting people back to the office (19:00). Later, Rick Heitzmann of FirstMark Capital joins Dan for a mid-year check on the private tech markets (26:00), M&A (33:00), and a study showing Wegovy cuts the risk of heart attacks (43:00).Articles mentioned on this podcast: WTF Happened In 2023? Venture Firms Still Writing Small Checks Despite $271 Billion in ‘Dry Powder’ The Unicorn Fire Sales Ahead Obesity Drug Wegovy Cuts Risk of Heart Attacks and Strokes by 20%, Study Shows ---View our show notes hereLearn more about Ro body: ro.co/okayEmail us at contact@riskreversal.com with any feedback, suggestions, or questions for us to answer on the pod and follow us @OkayComputerPod.We’re on social:Follow Dan Nathan @RiskReversal on TwitterFollow @GuyAdami on TwitterFollow us on Instagram @RiskReversalMediaSubscribe to our YouTube page

Rick Heitzmann, Founder and Managing Partner of FirstMark Capital, shares insights on the New York tech scene, value-added guilds, investment theses, and the venture environment. He discusses the transition from distressed investing to growth investing and the importance of aligning the investor's thesis with the entrepreneur's. Navigating changing market conditions, including path to profitability and capital efficiency, is also explored.

In this engaging discussion, investor Ambar Bhattacharyya dives into the key disruptors shaping the industry, emphasizing the importance of adapting to change. Rick Heitzmann forecasts the evolving landscape of venture capital, stressing the need for capital efficiency in the face of a challenging IPO market. Alexa von Tobel explores the anticipated disruptive forces of the next decade, hinting at the significant impact of technological advancements. Together, they paint a captivating picture of the future of venture funding.

Rick Heitzmann of First Mark discusses NYC vs. Bay Area, investing in DraftKings, AI's impact on SaaS, evaluating entrepreneurs' potential, and why remote work can ruin startups. Insights on unicorn selection, consumer investing, and the future of healthcare and video games.

Emi Gal and Rick Heitzmann discuss utilizing AI for early cancer detection, including revolutionizing MRI scans for improved outcomes and accessibility. They delve into partnerships with venture capital for innovation and the importance of biohacking for optimal health. The podcast explores the impact of AI in healthcare and the drive to increase adoption for early cancer detection.